136 related articles for article (PubMed ID: 3105357)
1. Effects of a specific benzodiazepine antagonist (RO 15-1788) on cerebral blood flow.
Forster A; Juge O; Louis M; Nahory A
Anesth Analg; 1987 Apr; 66(4):309-13. PubMed ID: 3105357
[TBL] [Abstract][Full Text] [Related]
2. [Assessment of the efficacy and tolerance of a benzodiazepine antagonist (Ro 15-1788)].
Rouiller M; Forster A; Gemperle M
Ann Fr Anesth Reanim; 1987; 6(1):1-6. PubMed ID: 3107442
[TBL] [Abstract][Full Text] [Related]
3. In vivo characterization of the pharmacodynamic interaction of a benzodiazepine agonist and antagonist: midazolam and flumazenil.
Mandema JW; Tukker E; Danhof M
J Pharmacol Exp Ther; 1992 Jan; 260(1):36-44. PubMed ID: 1309878
[TBL] [Abstract][Full Text] [Related]
4. [Acoustic and somatosensory evoked cortical potentials in sedation with midazolam and drug antagonism with flumazenil].
Kochs E; Wüst P; Blanc I; Schulte am Esch J
Anasth Intensivther Notfallmed; 1989 Feb; 24(1):49-56. PubMed ID: 2496619
[TBL] [Abstract][Full Text] [Related]
5. Effects of midazolam on cerebral hemodynamics and cerebral vasomotor responsiveness to carbon dioxide.
Forster A; Juge O; Morel D
J Cereb Blood Flow Metab; 1983 Jun; 3(2):246-9. PubMed ID: 6404914
[TBL] [Abstract][Full Text] [Related]
6. Early clinical pharmacological trials with a novel partial benzodiazepine agonist/antagonist Ro 17-1812 using pharmaco-EEG and psychometry.
Saletu B; Grünberger J; Linzmayer L
Methods Find Exp Clin Pharmacol; 1986 Jun; 8(6):373-89. PubMed ID: 3736281
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of a specific benzodiazepine antagonist (RO 15-1788). Studies in elderly patients after regional anaesthesia under benzodiazepine sedation.
Ricou B; Forster A; Brückner A; Chastonay P; Gemperle M
Br J Anaesth; 1986 Sep; 58(9):1005-11. PubMed ID: 3092849
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy and safety of the benzodiazepine antagonist RO 15-1788].
Ellmauer S; Müller H; Dick W
Anaesthesist; 1988 Jul; 37(7):432-9. PubMed ID: 3137835
[TBL] [Abstract][Full Text] [Related]
9. [The efficacy of the benzodiazepine antagonist flumazenil (Ro 15-1788) based on the EEG of mechanically ventilated intensive care patients].
Kulka PJ; Lauven PM; Schwilden H; Rommelsheim K
Anaesthesist; 1989 Aug; 38(8):424-30. PubMed ID: 2506776
[TBL] [Abstract][Full Text] [Related]
10. [The effect of midazolam on general hemodynamics and cerebral blood flow in animals and man (author's transl)].
Hilfiker O; Kettler D
Arzneimittelforschung; 1981; 31(12a):2236-7. PubMed ID: 7199327
[TBL] [Abstract][Full Text] [Related]
11. [Effect of flumazenil on global cerebral blood flow and on intracranial pressure in the reperfusion phase following incomplete global cerebral ischemia].
Kochs E; Roewer N; Peter A; Schulte am Esch J
Anasth Intensivther Notfallmed; 1988 Jun; 23(3):159-62. PubMed ID: 3135764
[TBL] [Abstract][Full Text] [Related]
12. Midazolam-ethanol interactions and reversal with a benzodiazepine antagonist.
Van Gorder PN; Hoffman WE; Baughman V; Albrecht RF; Miletich DJ; Guzman F; Cook JM
Anesth Analg; 1985 Feb; 64(2):129-35. PubMed ID: 2857540
[TBL] [Abstract][Full Text] [Related]
13. [Postoperative reversal of loss of vigilance following midazolam with the use of the antagonist flumazenil (Ro 15-1788). A comparative study with a placebo and the use of EEG-power spectra].
Freye E; Fournell A
Anaesthesist; 1988 Mar; 37(3):162-6. PubMed ID: 3132866
[TBL] [Abstract][Full Text] [Related]
14. The reversal of midazolam sedation with the benzodiazepine antagonist flumazenil (Anexate).
Merry AF; Clapham GJ; Walker JS
N Z Med J; 1988 Sep; 101(853):571-2. PubMed ID: 3138580
[TBL] [Abstract][Full Text] [Related]
15. [Beta activation following the intravenous administration of benzodiazepines and the specific antagonist flumazenil (Ro 15-1788)].
Suttmann H; Rampf U; Juhl G; Greim M; Doenicke A
EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1990 Mar; 21(1):20-8. PubMed ID: 1970957
[TBL] [Abstract][Full Text] [Related]
16. The effects of midazolam on cerebral blood flow and oxygen consumption and its interaction with nitrous oxide.
Hoffman WE; Miletich DJ; Albrecht RF
Anesth Analg; 1986 Jul; 65(7):729-33. PubMed ID: 2940942
[TBL] [Abstract][Full Text] [Related]
17. Cerebrovascular and cerebral metabolic effects of physostigmine, midazolam, and a benzodiazepine antagonist.
Hoffman WE; Albrecht RF; Miletich DJ; Hagen TJ; Cook JM
Anesth Analg; 1986 Jun; 65(6):639-44. PubMed ID: 2939779
[TBL] [Abstract][Full Text] [Related]
18. Respiratory depressant effects of different doses of midazolam and lack of reversal with naloxone--a double-blind randomized study.
Forster A; Morel D; Bachmann M; Gemperle M
Anesth Analg; 1983 Oct; 62(10):920-4. PubMed ID: 6137171
[TBL] [Abstract][Full Text] [Related]
19. [Hemodynamic effects of the benzodiazepine antagonist flumazenil following laparotomy under total intravenous anesthesia using midazolam].
Crozier TA; Sydow M; Müller J; Langenbeck M; Radke J; Kettler D
Anaesthesist; 1989 Apr; 38(4):193-9. PubMed ID: 2499212
[TBL] [Abstract][Full Text] [Related]
20. [Impairment of the cognitive faculties and the reaction capability caused by midazolam despite reversal using flumazenil].
Schlager A; Morawetz RF; Huber C; Furtwängler W; Luger TJ; Schreithofer D
Anaesthesist; 1991 Jan; 40(1):33-8. PubMed ID: 2006724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
